N
Núria Guimerà
Researcher at Universidad Nacional de Asunción
Publications - 23
Citations - 3734
Núria Guimerà is an academic researcher from Universidad Nacional de Asunción. The author has contributed to research in topics: Cervical cancer & HPV vaccines. The author has an hindex of 14, co-authored 22 publications receiving 3180 citations.
Papers
More filters
Journal ArticleDOI
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjosé,Wim Quint,Laia Alemany,D.T. Geraets,Jo Ellen Klaustermeier,Belen Lloveras,Sara Tous,Ana Félix,Luis Eduardo Bravo,Hai Rim Shin,Carlos S. Vallejos,Patricia Alonso de Ruiz,Marcus Aurelho Lima,Núria Guimerà,Omar Clavero,Maria Alejo,Antonio Llombart-Bosch,Chou Cheng-Yang,Silvio Tatti,Elena Kasamatsu,Ermina Iljazovic,Michael Odida,Rodrigo Prado,Muhieddine Seoud,Magdalena Grce,Alp Usubutun,Asha Jain,Gustavo Adolfo Hernandez Suarez,Luis Estuardo Lombardi,Aekunbiola Banjo,Clara Menendez,Efren J. Domingo,Julio Velasco,Ashrafun Nessa,Saibua Chichareon,You-Lin Qiao,Enrique Lerma,Suzanne M. Garland,Toshiyuki Sasagawa,Annabelle Ferrera,Doudja Hammouda,Luciano Mariani,Adela Pelayo,Ivo Šteiner,Esther Oliva,Chris J. L. M. Meijer,Waleed Al-Jassar,Eugenia Cruz,Thomas C. Wright,Ana Puras,Cecilia L. Llave,Maria Tzardi,Theodoros Agorastos,Victoria Garcia-Barriola,Christine Clavel,Jaume Ordi,Miguel Andújar,Xavier Castellsagué,Gloria I. Sanchez,Andrzej Nowakowski,Jacob Bornstein,Nubia Muñoz,F. Xavier Bosch +62 more
TL;DR: HPV types 16, 18, 31, 33, 35, 45, 52, and 58 should be given priority when the cross-protective effects of current vaccines are assessed, and for formulation of recommendations for the use of second-generation polyvalent HPV vaccines, according to this largest assessment of HPV genotypes to date.
Journal ArticleDOI
Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva
Silvia de Sanjosé,Laia Alemany,Jaume Ordi,Sara Tous,Maria Alejo,Susan M. Bigby,Elmar A. Joura,Paula Maldonado,Jan Laco,Ignacio G. Bravo,August Vidal,Núria Guimerà,Paul Cross,Gerard Wain,Karl Ulrich Petry,Luciano Mariani,Christine Bergeron,Václav Mandys,Adela Rosa Sica,Ana Félix,Alp Usubutun,Muhieddine Seoud,Gustavo Hernández-Suárez,Andrzej Nowakowski,G. Wilson,Véronique Dalstein,Monika Hampl,Elena Kasamatsu,Luis Estuardo Lombardi,Leopoldo Tinoco,Isabel Alvarado-Cabrero,Myriam Perrotta,Neerja Bhatla,Theodoros Agorastos,Charles F. Lynch,Marc T. Goodman,Hai Rim Shin,Halina Viarheichyk,Robert Jach,M. O.L.Eugenia Cruz,Julio Velasco,Carla Molina,Jacob Bornstein,Annabelle Ferrera,Efren J. Domingo,Cheng Yang Chou,Adekunbiola Aina Fehintola Banjo,Xavier Castellsagué,Michael Pawlita,Belen Lloveras,Wim Quint,Nubia Muñoz,F. Xavier Bosch +52 more
TL;DR: Combined data from HPV-DNA and p16(INK4a) testing are likely to represent a closer estimate of the real fraction of IVC induced by HPV, indicating that HPV contribution in invasive vulvar cancer has probably been overestimated.
Journal ArticleDOI
Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide.
Laia Alemany,Maëlle Saunier,Isabel Alvarado-Cabrero,Beatriz Quirós,Jorge Salmerón,Hai-Rim Shin,Edyta C. Pirog,Núria Guimerà,Gustavo Hernández-Suárez,Ana Félix,Omar Clavero,Belen Lloveras,Elena Kasamatsu,Marc T. Goodman,Marc T. Goodman,Brenda Y. Hernandez,Jan Laco,Leopoldo Tinoco,D.T. Geraets,Charles F. Lynch,Václav Mandys,Mario Poljak,Robert Jach,Josep Verge,Christine Clavel,Cathy Ndiaye,Joellen Klaustermeier,Antonio L. Cubilla,Xavier Castellsagué,Ignacio G. Bravo,Michael Pawlita,William G. Quint,Nubia Muñoz,Francesc Bosch,Silvia de Sanjosé +34 more
TL;DR: In view of the results of HPV DNA and high proportion of p16INK4a overexpression, infection by HPV is most likely to be a necessary cause for anal cancers in both men and women.
Journal ArticleDOI
Role of Human Papillomavirus in Penile Carcinomas Worldwide
Laia Alemany,Antonio L. Cubilla,Gordana Halec,Elena Kasamatsu,Beatriz Quirós,Emili Masferrer,Sara Tous,Belen Lloveras,Gustavo Hernández-Suárez,Ray Lonsdale,Leopoldo Tinoco,Maria Alejo,Isabel Alvarado-Cabrero,Jan Laco,Núria Guimerà,Enrique Poblet,Luis Estuardo Lombardi,Christine Bergeron,Omar Clavero,Hai-Rim Shin,Annabelle Ferrera,Ana Félix,Julieta Germar,Václav Mandys,Christine Clavel,Maria Tzardi,Luis E. Pons,Vincent Wain,Eugenia Cruz,Carla Molina,Jose D. Mota,Robert Jach,Julio Velasco,Carla Carrilho,Rubén López-Revilla,Marc T. Goodman,Marc T. Goodman,Wim Quint,Xavier Castellsagué,Ignacio G. Bravo,Michael Pawlita,Nubia Muñoz,F. Xavier Bosch,Silvia de Sanjosé +43 more
TL;DR: About a third to a fourth of penile cancers were related to HPV when considering HPV DNA detection alone or adding an HPV activity marker, respectively, and the observed HPV type distribution reinforces the potential benefit of current and new HPV vaccines in the reduction of HPV-related penile neoplastic lesions.
Journal ArticleDOI
HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases
Edyta C. Pirog,Belen Lloveras,Anco Molijn,Sara Tous,Núria Guimerà,Maria Alejo,Omar Clavero,Joellen Klaustermeier,David G. Jenkins,Wim Quint,Francesc Bosch,Laia Alemany,Silvia de Sanjosé +12 more
TL;DR: The results indicate that HPV vaccines may prevent up to 82.5% (HPV16/18) and up to 95.3% (9-valent vaccine) of HPV-positive cervical adenocarcinomas, mostly the classic type.